Injectable Fentanyl Vials Recalled Due to Sterility Assurance Failure
SSM Health Care is recalling 140 vials of fentanyl citrate injection because the manufacturer did not perform required process validation to ensure sterility.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This FDA Class II recall involves lack of sterility assurance in an injectable medication. Although no illnesses or injuries have been reported, the hazard is serious: injectable fentanyl with unvalidated sterilization poses potential for patient harm. Per the rubric, this is High severity due to a risk-of-harm product without reported injury.
Plain-English summary
SSM Health Care St. Louis is recalling 140 vials of fentanyl citrate injection (NDC: 60652-9010-1). The product is intended for intravenous use in hospital and office settings only.
The recall was initiated because the manufacturer failed to perform process validation, a required quality control procedure. Without process validation, there is no assurance that injectable medications maintain the sterility required for patient safety.
The affected lot (20231031-0C91D9) expired February 29, 2024. Distribution was limited to Missouri. Healthcare facilities should immediately quarantine any remaining vials from this lot and contact the manufacturer for return instructions.
The recalled product
- Product
- FentaNYL citrate, 10 mcg in 0.9% Sodium Chloride 1 mL Vial (10 mcg/mL), 1.5 mL Total Volume per Vial, Intravenous, Rx Only, Hospital/Office Use Only, SSM Health Care Corporation Outsourcing Facility, 1015 Bowles Ave, Fenton, MO 63026-2394. NDC: 60652-9010-1
- Manufacturer
- SSM Health Care St. Louis DBA SSM St. Clare Health Center
- Category
- Drug — Injectable Fentanyl
- Hazard
- contamination-risk
- sterility-assurance
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot: 20231031-0C91D9
- Exo 29-Feb-2024.
Distribution
Distributed in 1 state:
- MO
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27